Article: A long list of Anson short positions.Good post on Stockhouse here

Article - Media, Publications

A long list of Anson short positions.Good post on Stockhouse here

u/Rubarbarbara, Reddit, 17 March 2021

I have the full post below:We all know how the dirty rats at Anson Funds work. Wash trading, down ticking, spoofing among a host of other dirty tricks the banks let them get away with.

Then we have their army of social media bashers, their relationships with Nate Anderson at Hindenburg Research, Ben Axler at Sprucepoint Capital Management and Andrew Left at Citron Research, amongst many others. All of them in the pay of Moez and Anson Funds.

All working together to destroy companies and profit off their illegal deals.

Read Full Post

Article: This Top-Performing Pot Stock Was Accused of Fraud

Article - Media, Publications

This Top-Performing Pot Stock Was Accused of Fraud

Sean Williams, 19 December 2019

It’d be pretty fair to say that this is not how marijuana stock investors envisioned 2019 would go. After beginning the year on a (pardon the pun) high note, with more than a dozen pot stocks gaining in excess of 70% during the first quarter, the past 8.5 months have been nothing short of a train wreck.

To our north, Canada has struggled with the regulatory aspects of establishing a legal weed industry. Health Canada has been slow to approve cultivation, processing, and sales license applications, while Ontario, the most populous province, hasn’t approved retail store licenses in a timely manner. Meanwhile, high tax rates and a Swiss-cheese-like state-level approval process has constrained marijuana sales in legal U.S. states. In essence, the black market is thriving throughout North America.
Continue reading “Article: This Top-Performing Pot Stock Was Accused of Fraud”

Article: Citron Says the “Bidding Is On” for This Cannabis Company

Article - Media, Publications

Citron Says the “Bidding Is On” for This Cannabis Company

DANIEL LIBERTO, 19 December 2018

Famous short seller Andrew Left has high hopes for Aphria Inc. (APHA). In a research note, Left’s firm Citron Research claimed that the heavily shorted marijuana stock could hit $8 within the next two weeks because it has emerged as a prime acquisition target for either a major consumer packaged goods company or another marijuana producer.

“Expect an $APHA major partnership or total buyout SOON,” Citron tweeted on Tuesday after publishing its report. Citron’s bullish note, on top of news that Aphria expanded on an existing licensing agreement with Rapid Dose Therapeutics to offer its QuickStrip oral drug delivery system to customers in fast-growing marijuana market Germany, lifted the Canadian company’s shares 7.79% during Tuesday’s trading session.
Continue reading “Article: Citron Says the “Bidding Is On” for This Cannabis Company”

Article: More smoking guns will be revealed about Aphria, says short-seller

Article - Media, Publications

More smoking guns will be revealed about Aphria, says short-seller

Jayson MacLean, 06 December 2018

Recently emerged fraud allegations concerning marijuana company Aphria Inc (Aphria Stock Quote, Chart TSX, NYSE: APHA) may have already trashed the stock, but the worst could still be forthcoming, says short-seller Gabriel Grego, who claims there’s likely a lot more damning evidence to be revealed in the company’s documents.

A report released on Monday and co-authored by Hindenburg Research and Grego’s Quintessential Capital Management alleges that Aphria paid “vastly inflated” prices for essentially worthless assets in Latin America, in particular the $193-million purchase of LATAM Holdings, a subsidiary of Scythian Biosciences which has assets in Jamaica, Colombia and Argentina.
Continue reading “Article: More smoking guns will be revealed about Aphria, says short-seller”

Article: Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging

Article - Media, Publications

Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging

Lisa Bernard-Kuhn and Matt Lamers, 06 December 2018

The blows to Aphria’s stock continued Wednesday as the Canadian cannabis giant’s share price tumbled in the wake of a scathing short-seller report. Aphria’s stock (Nasdaq: APHA) closed Wednesday at $4.51 – down more than 25% for the day. The company has been on the defensive since Monday, refuting claims lobbed by short sellers Quintessential Capital Management and Hindenburg Research that Aphria’s management is a part of a shell game controlled by insiders raiding company coffers to line their own pockets. Aphria, in a statement issued Monday, called the allegations “malicious.”
Continue reading “Article: Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging”

Article: The marijuana producer Aphria is crashing after short seller alleges it’s a ‘shell game with a cannabis business on the side’ (APHA)

Article - Media, Publications

The marijuana producer Aphria is crashing after short seller alleges it’s a ‘shell game with a cannabis business on the side’ (APHA)

Ethel Jiang, 03 December 2018

The marijuana producer Aphria slumped as much as 30% — to a low of $5.60 a share — after a firm alleged the company’s business was full of overvalued buyouts and fraudulent financial reporting.
“Aphria is part of a scheme orchestrated by a network of insiders to divert funds away from shareholders into their own pockets,” short seller Quintessential Capital Management’s Hindenburg Research said Monday morning in a report titled “Aphria: a shell game with a cannabis business on the side.”
Continue reading “Article: The marijuana producer Aphria is crashing after short seller alleges it’s a ‘shell game with a cannabis business on the side’ (APHA)”

Article: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ACM Research (ACMR) Investors with Losses to Contact Its Attorneys, Securities Fraud Case Filed

Article - Media, Publications

The marijuana producer Aphria is crashing after short seller alleges it’s a ‘shell game with a cannabis business on the side’ (APHA)

Ethel Jiang, 03 December 2018

The marijuana producer Aphria slumped as much as 30% — to a low of $5.60 a share — after a firm alleged the company’s business was full of overvalued buyouts and fraudulent financial reporting. “Aphria is part of a scheme orchestrated by a network of insiders to divert funds away from shareholders into their own pockets,” short seller Quintessential Capital Management’s Hindenburg Research said Monday morning in a report titled “Aphria: a shell game with a cannabis business on the side.” Aphria responded Monday afternoon in a press release, referring Hindenburg Research’s report as “a malicious and self-serving attempt to profit by manipulating Aphria’s stock price at the expense of Aphria’s shareholders.”
Continue reading “Article: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ACM Research (ACMR) Investors with Losses to Contact Its Attorneys, Securities Fraud Case Filed”

Article: A Bull Market in Stock Bashing and 12 Stories from New Cannabis Ventures

Article - Media, Publications

A Bull Market in Stock Bashing and 12 Stories from New Cannabis Ventures

Alan Brochstein, 06 May 2018

With so much interest in the the cannabis sector, we have noticed an increase in the number of bearish pieces on publicly-traded companies on platforms like Seeking Alpha. This week, for instance, an article called for an 80% decline in Namaste Technologies. The same writer, “Grumpy Bear Research”, took a shot at Isodiol International in the prior week. Many of the leading LPs in Canada have been the subject of these attacks as well, including, most recently, Aphria.

We aren’t going to weigh in on the validity of the arguments made or our views of these companies, but we do want to discuss the bigger picture. Many, though certainly not all, of these articles are very well researched and bring out information that is new to many investors in the company, often a reflection of the lack of due diligence done by retail investors and the void in negative research published by the Canadian investment banking firms that cover the space.
Continue reading “Article: A Bull Market in Stock Bashing and 12 Stories from New Cannabis Ventures”